1. Home
  2. RGNX vs WNC Comparison

RGNX vs WNC Comparison

Compare RGNX & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • WNC
  • Stock Information
  • Founded
  • RGNX 2008
  • WNC 1985
  • Country
  • RGNX United States
  • WNC United States
  • Employees
  • RGNX N/A
  • WNC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • RGNX Health Care
  • WNC Industrials
  • Exchange
  • RGNX Nasdaq
  • WNC Nasdaq
  • Market Cap
  • RGNX 387.0M
  • WNC 425.6M
  • IPO Year
  • RGNX 2015
  • WNC 1991
  • Fundamental
  • Price
  • RGNX $8.75
  • WNC $10.70
  • Analyst Decision
  • RGNX Strong Buy
  • WNC Hold
  • Analyst Count
  • RGNX 8
  • WNC 1
  • Target Price
  • RGNX $31.75
  • WNC $9.50
  • AVG Volume (30 Days)
  • RGNX 1.2M
  • WNC 601.0K
  • Earning Date
  • RGNX 07-31-2025
  • WNC 07-23-2025
  • Dividend Yield
  • RGNX N/A
  • WNC 3.05%
  • EPS Growth
  • RGNX N/A
  • WNC N/A
  • EPS
  • RGNX N/A
  • WNC N/A
  • Revenue
  • RGNX $156,718,000.00
  • WNC $1,812,354,000.00
  • Revenue This Year
  • RGNX $327.08
  • WNC N/A
  • Revenue Next Year
  • RGNX N/A
  • WNC $18.83
  • P/E Ratio
  • RGNX N/A
  • WNC N/A
  • Revenue Growth
  • RGNX 80.70
  • WNC N/A
  • 52 Week Low
  • RGNX $5.04
  • WNC $6.78
  • 52 Week High
  • RGNX $15.36
  • WNC $24.03
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 48.33
  • WNC 57.59
  • Support Level
  • RGNX $7.82
  • WNC $10.01
  • Resistance Level
  • RGNX $10.64
  • WNC $10.68
  • Average True Range (ATR)
  • RGNX 0.71
  • WNC 0.40
  • MACD
  • RGNX -0.15
  • WNC 0.06
  • Stochastic Oscillator
  • RGNX 33.03
  • WNC 70.39

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: